UPDATE : Monday, February 18, 2019
Hanmi applies for breakthrough therapy designation for lung cancer drug
Spectrum, Hanmi Pharmaceutical’s U.S. partner, said Thursday that it has ap...
by Lee Han-soo  |  2018-11-09 16:41
Daewoong’s botulinum toxin wins indication for crow’s feet
Daewoong Pharmaceutical said it has expanded the indication of Nabota, the ...
by So Jae-hyeon  |  2018-11-09 15:27
[Exclusive] Wholesaler allegedly smuggled obesity drug Saxenda into China
A Korean wholesaler has allegedly smuggled popular obesity drug Saxenda int...
by So Jae-hyeon  |  2018-11-09 14:59
‘JAK inhibitors to change quality of life for people with polycythemia vera’
“Janus kinase (JAK) inhibitors, a type of medication that suppresses the ac...
by Park Gi-taek  |  2018-11-09 13:32
Sanofi releases 2 clinical trial results for antidiabetic treatment
Sanofi Aventis Korea has unveiled two phase 3 clinical trial results for So...
by Lee Han-soo  |  2018-11-08 17:13
Ildong Hyaltech to export HA filler to Brazil
Ildong Hyaltech, a subsidiary of Ildong Pharmaceutical, said Thursday that ...
by Lee Han-soo  |  2018-11-08 15:16
Dong-A ST’s athlete’s foot treatment exceeds annual sales of ₩10 billion
Dong-A ST said Thursday that Jublia, a toenail fungal treatment, has surpas...
by Lee Han-soo  |  2018-11-08 15:16
Well Marker Bio raises ₩28 billion for anticancer drug development
Anticancer treatment developer Well Marker Bio said it has completed the so...
by Lee Hye-seon  |  2018-11-08 15:10
Hanmi rolls out new generic drug to beat Pfizer’s anti-nicotine therapy
After failing to outrival Pfizer in the anti-smoking treatment market with ...
by So Jae-hyeon  |  2018-11-07 16:07
Ministry OKs P1 clinical trials for JW’s atopy treatment
JW Pharmaceutical said Wednesday that it has received approval from the Min...
by Lee Han-soo  |  2018-11-07 16:06
CJ HealthCare aims to add indication for Helicobacter eradication
CJ HealthCare is seeking to add an indication for the eradication of Helico...
by Lee Hye-seon  |  2018-11-07 14:58
Huons completes P3 clinical trials for Hutox
Huons Global said Tuesday that it has completed domestic phase 3 clinical t...
by Lee Han-soo  |  2018-11-07 12:26
Sanofi confirms continuous therapeutic benefits for relapsing-remitting multiple sclerosis treatment
Sanofi Genzyme Korea said Tuesday that it has presented a new study on Lemt...
by Lee Han-soo  |  2018-11-06 11:09
LG Chem to work on bilayer tablet for diabetes, dyslipidemia
LG Chem said it would start developing bilayer tablets of Zemiro (gemiglipt...
by Lee Hye-seon  |  2018-11-06 11:06
Celltrion wins suit against Roche to invalidate Herceptin patent in Japan
Korea’s biosimilar company Celltrion is likely to accelerate its move to ex...
by So Jae-hyeon  |  2018-11-05 15:26
GC starts developing shingles vaccine in US
GC said Monday that its U.S. subsidiary Cuervo has received U.S. Food and D...
by Lee Han-soo  |  2018-11-05 13:31
Lilly Korea’s rheumatoid arthritis treatment wins insurance coverage
Lilly Korea said Thursday that it has gained reimbursement for its rheumato...
by Lee Han-soo  |  2018-11-02 17:52
Why did pharmaceuticals release hair loss drugs in tablet form?
Why have Korean pharmaceutical companies released hair loss treatments in t...
by So Jae-hyeon  |  2018-11-02 12:43
Genexine wins FDA nod for clinical trials of HyLeukin-7
Genexine and NeoImmuneTech have received approval from the U.S. Food and Dr...
by Lee Han-soo  |  2018-11-01 11:03
Acer submits new drug application for rare disease to FDA
Acer Therapeutics, a NASDAQ-listed pharmaceutical firm in which Bukwang Pha...
by Park Gi-taek  |  2018-10-31 15:55
Back to Top